$0.860
-0.030 (-3.44%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BGMS Prediction & Forecast by Similar Chart Analysis
Alphio's BGMS stock price prediction model matches the current Bio Green Med Solution Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.86 (-0.38%). The 1-week path is $0.76 (-11.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bio Green Med Solution Inc Stock?
Bio Green Med Solution Inc (BGMS) is not a good buy right now. The stock has a current price of $0.86, which is significantly down 39.01% year-to-date and 86.49% over the past year. The RSI is at 31.619, indicating it is oversold, but this could also suggest continued weakness. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the gross margin is only 23.51%, which is low for a biotech company. The main risk is the high net income loss of $425,000 in Q2 2026, which raises concerns about the company's financial health.
BGMS stock price ended at $0.86 on Friday, after losing -3.44%
Bio Green Med Solution Inc (BGMS) last closed at $0.86, losing -3.44%. These facts feed the 1-day and 1-week BGMS price prediction above.
Forecast Drivers
Bio Green Med Solution Inc (BGMS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BGMS, ranked by similarity.
Seasonality analysis for BGMS
Historically the probability of a positive August return for BGMS is 0.00%. January offers the highest probability of a positive month at 20.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.